211 related articles for article (PubMed ID: 19357084)
1. Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors.
Turu G; Várnai P; Gyombolai P; Szidonya L; Offertaler L; Bagdy G; Kunos G; Hunyady L
J Biol Chem; 2009 Jun; 284(25):16914-16921. PubMed ID: 19357084
[TBL] [Abstract][Full Text] [Related]
2. Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.
Gyombolai P; Pap D; Turu G; Catt KJ; Bagdy G; Hunyady L
Mol Cell Endocrinol; 2012 Apr; 353(1-2):29-36. PubMed ID: 22075205
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats.
Gyires K; Rónai AZ; Zádori ZS; Tóth VE; Németh J; Szekeres M; Hunyady L
Mol Cell Endocrinol; 2014 Feb; 382(2):971-8. PubMed ID: 24145131
[TBL] [Abstract][Full Text] [Related]
4. Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.
Bonde MM; Hansen JT; Sanni SJ; Haunsø S; Gammeltoft S; Lyngsø C; Hansen JL
PLoS One; 2010 Nov; 5(11):e14135. PubMed ID: 21152433
[TBL] [Abstract][Full Text] [Related]
5. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity.
Turu G; Simon A; Gyombolai P; Szidonya L; Bagdy G; Lenkei Z; Hunyady L
J Biol Chem; 2007 Mar; 282(11):7753-7. PubMed ID: 17227758
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the fate of type I angiotensin receptor after biased activation.
Szakadáti G; Tóth AD; Oláh I; Erdélyi LS; Balla T; Várnai P; Hunyady L; Balla A
Mol Pharmacol; 2015 Jun; 87(6):972-81. PubMed ID: 25804845
[TBL] [Abstract][Full Text] [Related]
7. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
[TBL] [Abstract][Full Text] [Related]
8. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
10. BRET-based assay to monitor EGFR transactivation by the AT
O'Brien SL; Johnstone EKM; Devost D; Conroy J; Reichelt ME; Purdue BW; Ayoub MA; Kawai T; Inoue A; Eguchi S; Hébert TE; Pfleger KDG; Thomas WG
Biochem Pharmacol; 2018 Dec; 158():232-242. PubMed ID: 30347205
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization of wild type and nonfunctional mutant angiotensin II type I receptors inhibits galphaq protein signaling but not ERK activation.
Hansen JL; Theilade J; Haunsø S; Sheikh SP
J Biol Chem; 2004 Jun; 279(23):24108-15. PubMed ID: 15056658
[TBL] [Abstract][Full Text] [Related]
12. Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
Kim J; Ahn S; Rajagopal K; Lefkowitz RJ
J Biol Chem; 2009 May; 284(18):11953-62. PubMed ID: 19254952
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension.
Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Benyó Z; Offermanns S; Ruisanchez É; Szabó E; Takáts Z; Bátkai S; Tóth ZE; Hunyady L
Mol Cell Endocrinol; 2015 Mar; 403():46-56. PubMed ID: 25595485
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants in the second intracellular loop of the human cannabinoid CB1 receptor mediate selective coupling to G(s) and G(i).
Chen XP; Yang W; Fan Y; Luo JS; Hong K; Wang Z; Yan JF; Chen X; Lu JX; Benovic JL; Zhou NM
Br J Pharmacol; 2010 Dec; 161(8):1817-34. PubMed ID: 20735408
[TBL] [Abstract][Full Text] [Related]
15. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin mediates desensitization and internalization but does not affect dephosphorylation of the thyrotropin-releasing hormone receptor.
Jones BW; Hinkle PM
J Biol Chem; 2005 Nov; 280(46):38346-54. PubMed ID: 16183993
[TBL] [Abstract][Full Text] [Related]
17. Activation of extracellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation.
Miura S; Zhang J; Matsuo Y; Saku K; Karnik SS
Hypertens Res; 2004 Oct; 27(10):765-70. PubMed ID: 15785012
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone stimulates beta-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor.
Tilley DG; Nguyen AD; Rockman HA
Biochem Biophys Res Commun; 2010 Jun; 396(4):921-6. PubMed ID: 20460106
[TBL] [Abstract][Full Text] [Related]
19. A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell.
Azpiazu I; Gautam N
J Biol Chem; 2004 Jun; 279(26):27709-18. PubMed ID: 15078878
[TBL] [Abstract][Full Text] [Related]
20. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gα
Porcu A; Melis M; Turecek R; Ullrich C; Mocci I; Bettler B; Gessa GL; Castelli MP
Neuropharmacology; 2018 May; 133():107-120. PubMed ID: 29407764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
